Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran
,
Abstract
Background and Objective: Reports on MRSA strains are increasing worldwide. The aim of this study was to find the prevalence of MRSA strains isolated from clinical specimens and to evaluate their resistance profile. Additionally we compared the phenotypic and genotypic methods for detection of methicillin resistance.
Materials and Methods: In this cross-sectional study, a total of 41 isolates of S. aureus were collected from clinical specimens at two teaching hospitals in Ardabil, Iran. All isolates were identified at the species level by standard biochemical tests. The methicillin resistance were evaluated using three methods: PCR for mecA gene, agar dilution for determination of oxacillin MIC and disk diffusion test to detect methicillin, oxacillin and cefoxitin resistance. Antimicrobial resistance patterns were determined by disk diffusion method.
Results: The results identified 19 (46.3 %) out of 41 isolates as MRSA. Most of the MRSA strains (68.4%) were isolated from patients hospitalized in ICU. All isolates were susceptible to vancomycin, mupirocin and linezolid. Among other antibiotics co-trimoxazole was more active against MRSA isolates. Using PCR as reference method all the phenotypic tests showed 100% specificity. The sensitivity for MIC test and cefoxitin was 100% and for methicillin and oxacillin disks was 77.7% and 89.5%, respectively.
Conclusion: The prevalence of MRSA strains in our hospitals especially in ICU ward was high and disk diffusion testing using cefoxitin or oxacillin MIC test as an alternative to PCR for detection of MRSA is recommended.
Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 2005; 33: 3-8.
Johnson AP, Methicillin-resistant Staphylococcus aureus: the European landscape. J Antimicrob Chemother 2011; 66 Suppl 4: 43-48.
Watkins RR, David MZ, Salata RA. Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus. J Med Microbiol 2012; 61:1179-1193.
Eliopoulos GM. Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria. J Infect 2009; 59 Suppl 1: S17-24.
Cosgrove SE, Sakoulas G. Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin- susceptible Staphylococcus aureus bacteremia: a meta- analysis. Clin Infect Dis 2003; 36: 53-59.
Gordon RJ, Lowy FD. Pathogenesis of methicillin- resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46 Suppl 5:S350-359.
Stefani S, Chung DR, Lindsay JA, Friedrich AW, Kearns AM, Westh H, et al. Methicillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents 2012; 39: 273-282.
Sadeghi J, Mansouri S. Molecular characterization and antibiotic resistance of clinical isolates of methicillin- resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman). APMIS. 2013; DOI:10.1111/apm.12158.
Havaei SA, Azimian A, Fazeli H, Naderi M, Ghazvini K, Mirab Samiee S, et al. Isolation of Asian endemic and livestock associated clones of methicillin resistant Staphylococcus aureus from ocular samples in Northeastern Iran. Iran J Microbiol 2013; 5: 227-232.
Hasani A, Sheikhalizadeh V, Naghili B, Valizadeh V, Nikoonijad AR. Methicillin resistant and susceptible Staphylococcus aureus: Appraising therapeutic approaches in the Northwest of Iran. Iran J Microbiol 2013; 5: 56-62.
Abbasi-Montazeri E, Khosravi AD, Feizabadi MM, Goodarzi H, Khoramrooz SS, Mirzaii M, et al. The prevalence of methicillin resistant Staphylococcus aureus (MRSA) isolates with high-level mupirocin resistance from patients and personnel in a burn center. Burns 2013; 39: 650-654.
Askari E, Soleymani F, Arianpoor A, Tabatabai SM, Amini A, Nasab MN. Epidemiology of mecA- methicillin resistant Staphylococcus aureus in Iran: A systematic review and meta-analysis. Iran J Basic Med Sci 2012; 15: 1010-1019.
Clinical Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-first informational supplement M100-MS21. Wayne[PA]: Clinical and Laboratory Standards Institute; 2011.
Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin- resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991; 29: 2240-2244.
Mulder JG. Comparison of disk diffusion, the E test, and detection of mecA for determination of methicillin resistance in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 1996; 15: 567-573.
Farahani A, Mohajeri P, Gholamine B, Rezaei M, Abbasi H. Comparison of different phenotypic and genotypic methods for the detection of methicillin- resistant Staphylococcus aureus. N Am J Med Sci 2013;5: 637–640.
Hososaka Y, Hanaki H, Endo H, Suzuki Y, Nagasawa Z, Otsuka Y, et al. Characterization of oxacillin- susceptible mecA-positive Staphylococcus aureus: a new type of MRSA. J Infect Chemother 2007; 13: 79-
Jannati E, Arzanlou M, Habibzadeh S, Mohammadi S, Ahadi P, Mohammadi-Ghalehbin B, et al. Nasal colonization of mecA-positive, oxacillin-susceptible, methicillin-resistant Staphylococcus aureus isolates among nursing staff in an Iranian teaching hospital. Am J Infect Control 2013; 41: 1122-1124.
Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-644.
Hakan E, Selma K, Selcuk K, Tuna D, Iftihar K, Asuman I, et al. Withdrawal of Staphylococcus aureus from intensive care units in Turkey. Am J Infect Control 2013; 41: 1053-1058.
Schmitz FJ, Jones ME. Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices? Int J Antimicrob Agents 1997; 9: 1-19.
Aligholi M, Emaneini M, Jabalameli F, Shahsavan S, Dabiri H, Sedaght H. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med Princ Pract 2008; 17: 432-434.
Askari E, Tabatabai SM, Arianpoor A, Nasab MN.VanA-positive vancomycin-resistant Staphylococcus aureus: Systematic search and review of reported cases. Infect Dis Clin Pract 2013; 21: 91-93.
Azimian A, Havaei SA, Fazeli H, Naderi M, Ghazvini K, Mirab Samiee S, et al. Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran. J Clin Microbiol 2012; 50:3581–3585.
Ruef C. Epidemiology and clinical impact of glycopeptide resistance in Staphylococcus aureus. Infection 2004; 32: 315-327.
Lentino JR, Narita M, Yu VL. New antimicrobial agents as therapy for resistant gram-positive cocci. Eur J Clin Microbiol Infect Dis 2008; 27: 3-15.
Lyseng-Williamson KA, Goa KL. Linezolid: in infants and children with severe gram-positive infections. Paediatr Drugs 2003; 5: 419-429.
Ng J, Gosbell IB. Successful oral pristinamycin therapy for osteoarticular infections due to methicillin- resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp. J Antimicrob Chemother 2005; 55:1008-1012.
Keshari SS, Kapoor AK, Kastury N, Singh DK, Bhargava A. Emergence of pristinamycin resistance in India. Indian J Pharmacol 2009; 41: 47-48.
Verneuil L, Marchand C, Vidal JS, Ze Bekolo R, Daurel C, Lebouvier G, Leroy D, Leclercq R. Factors associated with emergence of pristinamycin-resistant Staphylococcus aureus in a dermatology department: a case-control study. Br J Dermatol 2010; 163: 329-333.
Samra Z, Gadba R, Ofir O. Antibiotic susceptibility and phage typing of methicillin-resistant and -sensitive Staphylococcus aureus clinical isolates at three periods during 1991-1997. Eur J Clin Microbiol Infect Dis 2001; 20: 425-427.
Bishara J, Pitlik S, Samra Z, Levy I, Paul M, Leibovici L. Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus, Israel, 1988-1997. Emerg Infect Dis 2003; 9: 1168-1169.
| Files | ||
| Issue | Vol 6 No 3 (2014) | |
| Section | Articles | |
| Keywords | ||
| Antibiotic resistance Methicillin resistance Staphylococcus aureus | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
